These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1469896)

  • 1. Molecular and endocrine biomarkers in non-involved breast: relevance to cancer chemoprevention.
    Telang NT; Bradlow HL; Osborne MP
    J Cell Biochem Suppl; 1992; 16G():161-9. PubMed ID: 1469896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.
    Telang NT; Kurihara H; Wong GY; Bradlow HL; Osborne MP
    Anticancer Res; 1991; 11(3):1021-7. PubMed ID: 1909512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative growth regulation of oncogene-transformed mammary epithelial cells by tumor inhibitors.
    Telang NT; Inoue S; Bradlow HL; Osborne MP
    Adv Exp Med Biol; 1997; 400A():409-18. PubMed ID: 9547584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.
    Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
    Breast Cancer Res Treat; 1993 Sep; 27(3):193-202. PubMed ID: 8312577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tamoxifen on mammary preneoplasia: relevance to chemopreventive intervention.
    Telang NT; Bradlow HL; Osborne MP
    Cancer Detect Prev; 1994; 18(4):313-21. PubMed ID: 7982241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-carbinol. A novel approach to breast cancer prevention.
    Bradlow HL; Sepkovic DW; Telang NT; Osborne MP
    Ann N Y Acad Sci; 1995 Sep; 768():180-200. PubMed ID: 8526347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.
    Abba MC; Hu Y; Levy CC; Gaddis S; Kittrell FS; Hill J; Bissonnette RP; Brown PH; Medina D; Aldaz CM
    Cancer Prev Res (Phila); 2009 Feb; 2(2):175-84. PubMed ID: 19174580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
    Fabian CJ; Kimler BF
    Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
    Green A; Shilkaitis A; Christov K
    Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early pathologic changes in experimental and human breast cancer: facts and comments.
    Squartini F; Bistocchi M; Sarnelli R; Basolo F
    Ann N Y Acad Sci; 1986; 464():231-61. PubMed ID: 3014948
    [No Abstract]   [Full Text] [Related]  

  • 11. A phase II chemoprevention trial design to identify surrogate endpoint biomarkers in breast cancer.
    Dhingra K
    J Cell Biochem Suppl; 1995; 23():19-24. PubMed ID: 8747374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells.
    Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
    Steroids; 1992 Jun; 57(6):262-8. PubMed ID: 1440696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals.
    Katdare M; Osborne MP; Telang NT
    Oncol Rep; 1998; 5(2):311-5. PubMed ID: 9468547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.
    Telang NT; Katdare M; Bradlow HL; Osborne MP
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):559-64. PubMed ID: 9167995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of mammary preneoplasia. In vitro effects of a green tea polyphenol.
    Araki R; Inoue S; Osborne MP; Telang NT
    Ann N Y Acad Sci; 1995 Sep; 768():215-22. PubMed ID: 8526351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.
    Grubbs CJ; Steele VE; Casebolt T; Juliana MM; Eto I; Whitaker LM; Dragnev KH; Kelloff GJ; Lubet RL
    Anticancer Res; 1995; 15(3):709-16. PubMed ID: 7645947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors.
    Katdare M; Singhal H; Newmark H; Osborne MP; Telang NT
    Cancer Lett; 1997 Jan; 111(1-2):141-7. PubMed ID: 9022139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
    Samanta SK; Sehrawat A; Kim SH; Hahm ER; Shuai Y; Roy R; Pore SK; Singh KB; Christner SM; Beumer JH; Davidson NE; Singh SV
    J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28040797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate biomarkers of precancer and their application in chemoprevention.
    Kelloff GJ; Malone WF; Boone CW; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16G():15-21. PubMed ID: 1469895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.